Jefferies Says No Changes to Ests on Amgen (AMGN) Amid Parsabiv CRL; Affirms at 'Buy'
Go back to Jefferies Says No Changes to Ests on Amgen (AMGN) Amid Parsabiv CRL; Affirms at 'Buy'| Amgen Inc (NASDAQ: AMGN) | Delayed: 410.24 +17.08 (4.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $393.16 | 52 Week High | $176.85 | |||
| Open | $405.25 | 52 Week Low | $133.64 | |||
| Day High | $413.00 | P/E | 61.78 | |||
| Day Low | $398.52 | EPS | $6.64 | |||
| Volume | 3,487,366 | |||||
